Parke Bancorp Reports Strong Q4 & Full-Year 2025 Earnings with Significant Net Income and EPS Growth
PKBK sits 56% above its 52-week low of $16.94.
Summary
Parke Bancorp announced strong Q4 and full-year 2025 results, with net income and diluted EPS increasing significantly, driven by higher net interest income and loan growth.
Key Events · Earnings and Guidance · PKBK
-
Strong Q4 and Full-Year Net Income Growth
Net income available to common shareholders increased by 49.9% to $11.1 million in Q4 2025 and by 37.3% to $37.8 million for the full fiscal year 2025, compared to the prior year periods.
-
Significant EPS Increase
Diluted earnings per common share rose 52.5% to $0.93 in Q4 2025 and 39.2% to $3.16 for the full fiscal year 2025.
-
Healthy Loan and Deposit Growth
Total loans grew 8.9% to $2.04 billion and total deposits increased 7.8% to $1.80 billion at December 31, 2025, compared to December 31, 2024.
-
Improved Asset Quality
Nonperforming loans decreased by $1.0 million to $10.8 million (0.53% of total loans), and the allowance for credit losses to non-performing loans improved to 321.0% at year-end 2025.
Analysis · PKBK · Finance
Parke Bancorp delivered a robust financial performance for both the fourth quarter and full fiscal year 2025, marked by substantial increases in net income and earnings per share. The significant growth was primarily driven by a strong rise in net interest income and healthy loan growth, alongside disciplined expense management. Despite a challenging macroeconomic and geopolitical environment, as noted by the CEO, the company demonstrated resilience and improved key financial metrics, including asset quality. The decrease in nonperforming loans and enhanced allowance for credit losses coverage indicate a solid financial position. The stock trading near its 52-week high reflects investor confidence in the company's performance and outlook.
At the time of this filing, PKBK was trading at $26.49 on NASDAQ in the Finance sector, with a market capitalization of approximately $306.5M. The 52-week trading range was $16.94 to $26.98. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.